TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.
Market News Page 7 of 234 • 5,848 articles
Man Group PLC : Form 8.3 - American Axle & Manufacturing Holdings, Inc
GlobeNewswire Inc. • Na
Man Group PLC : Form 8.3 - American Axle & Manufacturing Holdings, Inc

12/24/2025 04:00 AM • Man Group PLC has filed a Form 8.3 disclosure revealing its interests in American Axle & Manufacturing Holdings, Inc. and Dowlais Group plc. The disclosure shows Man Group holds 258,414 common shares (0.21%) and cash-settled derivatives totaling 1,994,185 shares (1.68%) in American Axle & Manufacturing as of December 23, 2025. Recent dealings include increasing short positions through swap transactions.

AMCR - Steady packaging business with global consumer and healthcare clients, 6.1% dividend yield, raised EPS guidance, but mixed financial health profile
AXL - Man Group has increased short positions in American Axle & Manufacturing through swap transactions, suggesting a bearish outlook on the company's near-term performance.
#Form 8.3 disclosure #takeover code #relevant securities #short position #cash-settled derivatives #public opening position disclosure
Read More
CorMedix Builds a Real Revenue Story as DefenCath Adoption Accelerates
Investing.com • Nathan Reiff
CorMedix Builds a Real Revenue Story as DefenCath Adoption Accelerates

12/24/2025 03:42 AM • CorMedix is experiencing strong commercial momentum with its DefenCath catheter lock solution, which has shown a 72% reduction in catheter-related bloodstream infections in real-world evidence studies. The company reported Q3 2025 net revenue of $104.3 million and raised full-year guidance to $390-410 million. DefenCath adoption is outpacing expectations, and the Melinta Therapeutics acquisition adds diversification. Analysts are optimistic with nearly-unanimous Buy ratings and see 48% upside potential, though risks include pricing pressure and pipeline concentration.

CRMD - Strong commercial execution with DefenCath adoption exceeding targets, significant revenue growth ($104.3M Q3 2025), raised full-year guidance, impressive adjusted EBITDA improvement ($72M vs -$2M prior year), strategic acquisition of Melinta adding revenue diversification, nearly-unanimous Wall Street Buy ratings, and promising Phase III pipeline data expected in Q2 2026. Stock has already gained 51% YTD with analysts seeing 48% additional upside.
#DefenCath #catheter lock solution #dialysis infections #real-world evidence #commercial adoption #Melinta Therapeutics acquisition #REZZAYO #Phase III trial #revenue growth #EBITDA expansion
Read More
Movement และ KAST ปลดล็อกการใช้จ่ายสเตเบิลคอยน์ที่ร้านค้ากว่า 150 ล้านแห่ง พร้อมรับรางวัล 4%
GlobeNewswire Inc. • Not Specified
Movement และ KAST ปลดล็อกการใช้จ่ายสเตเบิลคอยน์ที่ร้านค้ากว่า 150 ล้านแห่ง พร้อมรับรางวัล 4%

12/24/2025 01:52 AM • Movement Network announced a partnership with KAST, a mobile-first payment platform, enabling over 500,000 KAST users to earn $MOVE tokens on transactions at 150M+ Visa-accepting merchants worldwide. Users receive 4% rewards in $MOVE tokens plus existing KAST Points, creating the first dual-rewards crypto card program. The collaboration aims to build a circular economy between daily commerce and on-chain participation.

TpC - High 4.4% dividend yield, surging free cash flow, successful strategic initiatives, strong wireless segment, and significant potential upside according to analyst targets
V - Mentioned as infrastructure partner through merchant network acceptance. While the partnership validates stablecoin spending growth (4x increase reported), Visa is not a direct party to the announcement and serves primarily as a reference point for merchant reach.
#cryptocurrency payments #stablecoin #mobile payment platform #blockchain #crypto rewards #Movement Network #KAST #financial inclusion #dual-rewards program
Read More
Movement dan KAST Membolehkan Perbelanjaan Stablecoin di Lebih 150 Juta Peniaga dengan Ganjaran 4%
GlobeNewswire Inc. • Not Specified
Movement dan KAST Membolehkan Perbelanjaan Stablecoin di Lebih 150 Juta Peniaga dengan Ganjaran 4%

12/24/2025 01:52 AM • Movement Network announced a partnership with KAST, a mobile payment platform, enabling over 500,000 KAST users to earn 4% rewards in $MOVE tokens on crypto purchases at 150+ million Visa merchants worldwide. The collaboration creates a dual-rewards system combining KAST Points and $MOVE tokens, positioning Movement as a practical blockchain solution for everyday transactions amid growing stablecoin adoption.

TpA - High 4.4% dividend yield, surging free cash flow, successful strategic initiatives, strong wireless segment, and significant potential upside according to analyst targets
V - Visa is mentioned as the underlying payment network infrastructure supporting the partnership (150M+ merchants), but the announcement does not directly impact Visa's business operations or strategy. Visa serves as a neutral enabler of the transaction infrastructure.
#Movement Network #KAST #stablecoin #crypto payments #MOVE token #blockchain #mobile payments #rewards program
Read More
Movement und KAST ermöglichen Stablecoin-Zahlungen bei über 150 Mio. Händlern – inklusive 4 % Rewards
GlobeNewswire Inc. • Not Specified
Movement und KAST ermöglichen Stablecoin-Zahlungen bei über 150 Mio. Händlern – inklusive 4 % Rewards

12/24/2025 01:52 AM • Movement Network has partnered with KAST, a mobile-first payments platform, to enable stablecoin payments at over 150 million Visa merchants worldwide. Users can earn 4% cashback in $MOVE tokens on transactions, creating a dual-rewards system combining KAST Points and $MOVE tokens. This partnership represents the first spending-rewards program for Movement and addresses the growing mainstream adoption of stablecoins in fintech.

TBB - High 4.4% dividend yield, surging free cash flow, successful strategic initiatives, strong wireless segment, and significant potential upside according to analyst targets
V - Mentioned as the underlying payment network infrastructure supporting the partnership; while the article notes Visa's growing stablecoin transaction volumes, Visa itself is not a direct party to this partnership and serves primarily as the enabling infrastructure.
#stablecoin payments #Movement Network #KAST partnership #crypto rewards #mobile payments #blockchain #People's Chain #Visa merchants
Read More
Movement dan KAST Buka Akses Bayar dengan Stablecoin di Lebih dari 150 Juta Merchant Global, dengan Reward 4%
GlobeNewswire Inc. • Not Specified
Movement dan KAST Buka Akses Bayar dengan Stablecoin di Lebih dari 150 Juta Merchant Global, dengan Reward 4%

12/24/2025 01:52 AM • Movement Network partnered with KAST to enable cryptocurrency payments at over 150 million merchants globally through Visa-accepting outlets. Users can earn 4% rewards in $MOVE tokens on purchases, creating a dual-reward system combining KAST Points with cryptocurrency incentives. The partnership aims to drive real-world utility of stablecoins and build a circular economy connecting daily commerce with blockchain participation.

T - High 4.4% dividend yield, surging free cash flow, successful strategic initiatives, strong wireless segment, and significant potential upside according to analyst targets
V - Mentioned as the underlying payment network infrastructure enabling the partnership. While the partnership leverages Visa's merchant network, there is no direct business impact or strategic involvement indicated for Visa itself.
#stablecoin payments #cryptocurrency rewards #Movement Network #KAST partnership #blockchain adoption #mobile payments #merchant integration #dual-rewards program
Read More
Carnival’s Dividend Return Marks the End of Survival Mode
Investing.com • Jeffrey Neal Johnson
Carnival’s Dividend Return Marks the End of Survival Mode

12/24/2025 12:40 AM • Carnival Corporation has officially ended its post-pandemic survival phase by reinstating its quarterly dividend (15 cents per share) for the first time since 2020. The cruise operator achieved record financial results in 2025, including $7.2 billion in adjusted EBITDA, $3.1 billion in adjusted net income (60% YoY growth), and reduced debt by over $10 billion. With a net debt-to-adjusted EBITDA ratio of 3.4x (approaching investment grade), two-thirds of 2026 inventory already booked at premium prices, and a planned corporate restructuring to unify its dual-listed structure, Carnival has transitioned from a recovery story to a growth and capital returns story.

UTZ - Reported organic sales growth, increased cash reserves, expanded distribution, improved gross profit margin, and price target significantly higher than current trading price
CCL - Company has successfully exited survival mode with record financial results, achieved investment-grade leverage ratios, reinstated dividends, reduced debt significantly, and demonstrated strong consumer demand with 2/3 of 2026 inventory pre-booked at premium prices. Strategic initiatives like the new private destination and planned corporate unification provide additional growth catalysts.
#dividend reinstatement #cruise industry recovery #debt reduction #record earnings #capital returns #balance sheet improvement #booking demand #corporate restructuring
Read More
Amazon Looks Stuck—So Why Do Analysts Keep Calling for $300?
Investing.com • Sam Quirke
Amazon Looks Stuck—So Why Do Analysts Keep Calling for $300?

12/24/2025 12:33 AM • Amazon stock is trading around $230, up 40% from April lows but stuck below November highs and near year-start levels. Multiple analysts (BMO Capital Markets, Cowen, JPMorgan) maintain bullish $300+ price targets, citing improving operating leverage and higher-margin segment growth. However, the stock has been consolidating in a narrow range since July, suggesting the market is waiting for concrete evidence of margin improvement and earnings power before making the next move higher.

AMZN - Multiple reputable analysts (BMO Capital Markets, Cowen, JPMorgan) reiterated bullish ratings with $300-$305 price targets, representing 30% upside. Analysts cite improving operating leverage, steady growth in higher-margin segments, and a more disciplined core retail business. The stock's consolidation pattern after a 40% rally is viewed as constructive digestion rather than weakness, suggesting a setup for further gains once a catalyst emerges.
#Amazon stock consolidation #analyst price targets #operating leverage #earnings power #technical resistance #bullish catalysts
Read More
ROSEN, HIGHLY RANKED INVESTOR COUNSEL, Encourages SLM Corporation a/k/a Sallie Mae Investors to Secure Counsel Before Important Deadline in Securities Class Action – SLM
GlobeNewswire Inc. • Rosen Law Firm
ROSEN, HIGHLY RANKED INVESTOR COUNSEL, Encourages SLM Corporation a/k/a Sallie Mae Investors to Secure Counsel Before Important Deadline in Securities Class Action – SLM

12/23/2025 11:56 PM • Rosen Law Firm has filed a class action lawsuit against SLM Corporation (Sallie Mae) on behalf of investors who purchased securities between July 25, 2025 and August 14, 2025. The lawsuit alleges that SLM made false and misleading statements regarding early stage delinquencies and overstated the effectiveness of its loss mitigation programs for private education loans. The deadline to serve as lead plaintiff is February 17, 2026.

SLM - The company is the subject of a securities class action lawsuit alleging material misstatements and omissions regarding loan delinquencies and the effectiveness of loss mitigation programs, which caused investor damages when the true details became public.
#class action lawsuit #securities fraud #SLM Corporation #Sallie Mae #delinquencies #loan modification #investor compensation #lead plaintiff deadline
Read More
ALVO Investor News: If You Have Suffered Losses in Alvotech (NASDAQ: ALVO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
GlobeNewswire Inc. • Rosen Law Firm
ALVO Investor News: If You Have Suffered Losses in Alvotech (NASDAQ: ALVO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

12/23/2025 11:45 PM • The Rosen Law Firm is investigating potential securities claims against Alvotech (NASDAQ: ALVO) following allegations of materially misleading business information. The investigation was triggered by Alvotech's November 2, 2025 announcement that the FDA issued a complete response letter for its AVT05 biologics license application, citing manufacturing deficiencies. The stock fell 34% on November 3, 2025, following the news. Investors who suffered losses are encouraged to join a prospective class action lawsuit.

NEM - Gold mining company with low P/E ratio, experiencing price volatility but maintaining strong potential with price target above current trading level
ALVO - The company issued materially misleading information regarding its FDA application status. The FDA's complete response letter citing manufacturing deficiencies resulted in a 34% stock price decline, triggering a securities class action investigation for investor losses.
#securities fraud #class action lawsuit #FDA rejection #biologics license application #manufacturing deficiencies #investor losses #stock decline
Read More
Synopsys, Inc. Notice of December 30, 2025 Application Deadline for Class Action Lawsuit- Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
GlobeNewswire Inc. • Kahn Swick & Foti, Llc
Synopsys, Inc. Notice of December 30, 2025 Application Deadline for Class Action Lawsuit- Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

12/23/2025 10:37 PM • Kahn Swick & Foti, LLC announces a class action securities lawsuit against Synopsys, Inc. for alleged securities fraud between December 4, 2024 and September 9, 2025. The lawsuit was triggered after Synopsys missed Q3 2025 revenue guidance ($1.740B vs. $1.755-1.785B guidance) and reported a 43% year-over-year decline in net income. The Design IP segment declined 7.7% year-over-year with guidance suggesting at least 5% full-year decline. Stock price fell 35.8% on the announcement. Investors have until December 30, 2025 to request lead plaintiff status.

JPMpL - Set a fresh record, stock price increased 1.90%
SNPS - Company missed quarterly revenue guidance, reported significant year-over-year net income decline of 43%, Design IP segment declined 7.7% with negative full-year outlook, and stock price fell 35.8% on the announcement. These factors triggered a securities fraud class action lawsuit.
#class action lawsuit #securities fraud #missed revenue guidance #earnings decline #stock price drop #Design IP segment #lead plaintiff deadline
Read More
Jayud Global Logistics Ltd. Notice of January 19, 2026 Application Deadline for Class Action Lawsuit- Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
GlobeNewswire Inc. • Kahn Swick & Foti, Llc
Jayud Global Logistics Ltd. Notice of January 19, 2026 Application Deadline for Class Action Lawsuit- Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

12/23/2025 10:35 PM • Kahn Swick & Foti, LLC announces a class action securities lawsuit against Jayud Global Logistics Limited for alleged securities fraud between April 21, 2023 and April 30, 2025. The lawsuit claims the company was subject to a fraudulent 'pump-and-dump' scheme involving social media misinformation, impersonated financial professionals, and coordinated share dumping by insiders using offshore accounts. Investors who suffered losses have until January 19, 2026 to request lead plaintiff status.

JPMpM - Set a fresh record, stock price increased 1.90%
JYD - The company is the subject of a class action lawsuit alleging securities fraud, fraudulent stock promotion schemes, market manipulation through coordinated share dumping, and materially misleading public statements about business operations and prospects.
#class action lawsuit #securities fraud #pump-and-dump scheme #stock manipulation #investor losses #misleading statements #offshore accounts
Read More
DeFi Technologies Inc. Notice of January 30, 2026 Application Deadline for Class Action Lawsuit- Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
GlobeNewswire Inc. • Kahn Swick & Foti, Llc
DeFi Technologies Inc. Notice of January 30, 2026 Application Deadline for Class Action Lawsuit- Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

12/23/2025 10:34 PM • A class action securities lawsuit has been filed against DeFi Technologies Inc. (DEFT) for alleged fraud between May 12 and November 14, 2025. The company disclosed a 20% revenue decline and slashed its 2025 revenue forecast from $218.6 million to $116.6 million, citing delays in executing arbitrage opportunities. The stock fell 27.59% following the announcement. Investors have until January 30, 2026 to apply as lead plaintiffs.

VYLD - Set a fresh record, stock price increased 1.90%
DEFT - The company faces a class action lawsuit for alleged securities fraud, disclosed a nearly 20% revenue decline significantly below expectations, slashed full-year revenue guidance by 46% (from $218.6M to $116.6M), and experienced a 27.59% stock price decline following the announcement. These factors indicate serious operational and financial challenges.
#class action lawsuit #securities fraud #revenue decline #stock price drop #DeFi Technologies #financial misstatement
Read More
F5, Inc. Securities Fraud Class Action Result of Data Breach and Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
GlobeNewswire Inc. • Kahn Swick & Foti, Llc
F5, Inc. Securities Fraud Class Action Result of Data Breach and Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

12/23/2025 10:33 PM • F5, Inc. faces a securities class action lawsuit for failing to disclose material information about a security breach in its BIG-IP product during the Class Period (October 28, 2024 - October 27, 2025). The company announced significantly below-market growth expectations for fiscal 2026, resulting in a 10.9% stock price decline from $290.41 to $258.76 per share on October 27-28, 2025. Investors have until February 17, 2026 to file lead plaintiff applications.

CRCL - Slumped more than 10% despite beating earnings expectations due to higher-than-expected operating costs
FFIV - F5 faces securities fraud allegations for failing to disclose a material security breach affecting its highest revenue product (BIG-IP). The company disclosed significantly below-market growth expectations, reduced sales projections, and increased expenses. The stock declined 10.9% following the announcement, and investors are pursuing legal action for economic losses.
#securities fraud #class action lawsuit #data breach #BIG-IP #stock decline #material information disclosure #lead plaintiff
Read More
Coupang, Inc. Securities Fraud Class Action Result of Data Breach and Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
GlobeNewswire Inc. • Kahn Swick & Foti, Llc
Coupang, Inc. Securities Fraud Class Action Result of Data Breach and Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

12/23/2025 10:32 PM • Coupang, Inc. faces a securities class action lawsuit for allegedly failing to disclose a material data breach where a former employee accessed sensitive customer information for nearly six months without detection. Investors who purchased securities between August 6, 2025 and December 16, 2025 can file lead plaintiff applications by February 17, 2026. The lawsuit alleges the company violated federal securities laws by not properly reporting the breach and making false public statements.

CPNG - The company is facing securities fraud allegations for inadequate cybersecurity protocols, failure to disclose a material data breach, and non-compliance with SEC reporting requirements. These violations resulted in stock decline and investor losses during the class period.
#data breach #securities fraud #class action lawsuit #cybersecurity #material disclosure #SEC reporting #investor losses
Read More
Bitdeer Technologies Group Securities Fraud Class Action Result of Undisclosed Financial Problems and 14% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
GlobeNewswire Inc. • Kahn Swick & Foti, Llc
Bitdeer Technologies Group Securities Fraud Class Action Result of Undisclosed Financial Problems and 14% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

12/23/2025 10:31 PM • Bitdeer Technologies Group faces a securities class action lawsuit for failing to disclose material financial information during the period from June 6, 2024 to November 10, 2025. The company announced a widened net loss of $266.7 million in Q3 2025 due to increased R&D expenses, causing its stock to plummet 14% from $17.65 to $15.02 per share. Investors have until February 2, 2026 to file lead plaintiff applications.

BULLW - The company is proactively adopting innovative AI technology to enhance user experience, differentiate from competitors, and provide more targeted investment information
BTDR - The company is facing securities fraud allegations for failing to disclose material financial information. It reported a significantly widened net loss of $266.7 million in Q3 2025, and its stock declined 14% following the announcement. These factors indicate serious financial and legal troubles.
#securities fraud #class action lawsuit #undisclosed financial problems #stock decline #net loss #ASIC roadmap #Bitcoin mining
Read More
Hainan FTP's customs closure begins: departure of duty-free processed and value-added goods from island
GlobeNewswire Inc. • The Publicity Department Of The Sanya Municipal Party Committee
Hainan FTP's customs closure begins: departure of duty-free processed and value-added goods from island

12/23/2025 09:53 PM • Hainan Heren Pearl Co., Ltd. shipped the first batch of duty-free processed jewelry from Sanya following the customs closure at Hainan Free Trade Port. The company reduced its comprehensive tax rate from 51.92% to 25.56%, lowering production costs. Sanya has attracted major jewelry companies and established industrial parks, with 9,838 new declaration units registered this year and 650 million yuan in zero-tariff imports generating 150 million yuan in tax savings.

JPMpD - Set a fresh record, stock price increased 1.90%
ZHAOY - Established presence in Sanya's jewelry industrial parks, benefiting from FTP policies and the developing full-chain industrial ecosystem.
#Hainan Free Trade Port #duty-free processing #jewelry industry #tax reduction #industrial cluster #value-added goods #Sanya customs
Read More
TLX DEADLINE: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Telix Pharmaceuticals Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – TLX
GlobeNewswire Inc. • Rosen Law Firm
TLX DEADLINE: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Telix Pharmaceuticals Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – TLX

12/23/2025 09:44 PM • Rosen Law Firm reminds investors in Telix Pharmaceuticals Ltd. (NASDAQ: TLX) who purchased securities between February 21, 2025 and August 28, 2025 of the January 9, 2026 lead plaintiff deadline in an ongoing securities class action. The lawsuit alleges that Telix made materially false and misleading statements regarding progress on prostate cancer therapeutics, supply chain quality, and business prospects.

JPMpJ - Set a fresh record, stock price increased 1.90%
TLX - The company is the subject of a securities class action lawsuit alleging material misstatements and omissions regarding prostate cancer therapeutic progress, supply chain quality, and business operations. Investors who purchased during the class period may have suffered damages.
#securities class action #lead plaintiff deadline #Telix Pharmaceuticals #false statements #prostate cancer therapeutics #supply chain #investor compensation
Read More
NUAI Announcement: If You Have Suffered Losses in New Era Energy & Digital, Inc. (NASDAQ: NUAI), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
GlobeNewswire Inc. • The Rosen Law Firm
NUAI Announcement: If You Have Suffered Losses in New Era Energy & Digital, Inc. (NASDAQ: NUAI), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

12/23/2025 09:38 PM • The Rosen Law Firm announced an investigation into potential securities claims against New Era Energy & Digital, Inc. (NASDAQ: NUAI) following a short seller report by Fuzzy Panda Research alleging the company spent 2.5 times more on stock promotions than operating expenses and that CEO E. Will Gray II has a history of running penny stock companies into the ground. The stock fell 6.9% on December 12, 2025, following the report's release.

JPMpK - Set a fresh record, stock price increased 1.90%
NUAI - The company faces allegations of issuing materially misleading information, excessive spending on stock promotions relative to operations, and CEO's history of mismanagement. Stock declined 6.9% following the short seller report, and a securities class action investigation has been initiated.
#securities fraud #class action lawsuit #short seller report #stock promotion #penny stock #investor losses #misleading business information
Read More
Is Amazon Stock Still a Buy After Hitting All-Time Highs?
The Motley Fool • Manali Pradhan, Cfa
Is Amazon Stock Still a Buy After Hitting All-Time Highs?

12/23/2025 08:37 PM • Amazon stock has reached all-time highs but analysts believe it can continue climbing. AWS cloud services are experiencing strong growth with a $200 billion backlog driven by AI infrastructure demand, while the advertising business is becoming increasingly profitable. The company plans significant capital investments in AI infrastructure, positioning it for accelerated growth despite current valuation levels.

JPMpC - Set a fresh record, stock price increased 1.90%
AMZN - AWS shows robust 20.2% YoY revenue growth with $200B backlog providing multiyear visibility; advertising revenue grew 22% YoY and is becoming highly profitable; company planning major AI infrastructure investments; analyst expects stock can surpass all-time highs despite current elevated valuations
#Amazon #AWS #cloud computing #artificial intelligence #advertising revenue #capital investment #stock valuation
Read More
Dr. Andrea Adams-Miller Warns Boards Face Rising Governance Risk as AI Outpaces Human Judgment
GlobeNewswire Inc. • Dr. Andrea Adams-Miller
Dr. Andrea Adams-Miller Warns Boards Face Rising Governance Risk as AI Outpaces Human Judgment

12/23/2025 07:51 PM • Dr. Andrea Adams-Miller warns that rapid AI expansion in companies has created a governance gap that boards have not adequately addressed. As AI systems guide critical business decisions faster than leaders can evaluate them, boards face increased risk. Recent cases at Amazon and Zillow highlight governance failures when oversight lags behind technology. Adams-Miller recommends boards implement clear human ownership, plain-language explanations, defined pause points, and communication readiness for AI-driven decisions.

GSpD - Set a fresh record, stock price increased 2.73%
AMZN - Company cited as a cautionary example of governance failure; leadership had to shut down an internal AI hiring tool after it demonstrated bias against female candidates, indicating inadequate review and testing processes.
#AI governance #corporate boards #risk management #decision-making #AI oversight #leadership accountability #regulatory concerns
Read More
U.S. FDA Approves Agios’ AQVESME™ (mitapivat) for the Treatment of Anemia in Adults with Alpha- or Beta-Thalassemia
GlobeNewswire Inc. • Agios Pharmaceuticals, Inc.
U.S. FDA Approves Agios’ AQVESME™ (mitapivat) for the Treatment of Anemia in Adults with Alpha- or Beta-Thalassemia

12/23/2025 07:45 PM • The FDA has approved Agios Pharmaceuticals' AQVESME (mitapivat), an oral pyruvate kinase activator, for treating anemia in adults with alpha- or beta-thalassemia. AQVESME is the only FDA-approved medicine for both non-transfusion-dependent and transfusion-dependent forms of the disease. The approval is based on Phase 3 ENERGIZE and ENERGIZE-T trials showing significant improvements in hemoglobin levels, fatigue, and transfusion burden. The drug will be available in late January 2026 under a REMS program due to hepatocellular injury risks observed in clinical trials.

AMJB - Set a fresh record, stock price increased 1.90%
AGIO - FDA approval of AQVESME represents a significant milestone for the company, establishing it as the only approved treatment for both transfusion-dependent and non-transfusion-dependent thalassemia. The approval is based on successful Phase 3 trials meeting primary and secondary endpoints. However, the positive sentiment is tempered by the requirement for a restrictive REMS program due to hepatocellular injury risks observed in 5 patients during trials, which may impact market adoption and commercial success.
#FDA approval #mitapivat #thalassemia #anemia treatment #pyruvate kinase activator #ENERGIZE trials #REMS program #hepatocellular injury #rare disease
Read More
NJDCY Announcement: If You Have Suffered Losses in Nidec Corporation (OTC: NJDCY), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
GlobeNewswire Inc. • The Rosen Law Firm
NJDCY Announcement: If You Have Suffered Losses in Nidec Corporation (OTC: NJDCY), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

12/23/2025 07:32 PM • The Rosen Law Firm is investigating potential securities claims against Nidec Corporation after the company announced a probe into accounting issues at its China unit. Nidec's ADRs fell 22.7% on September 4, 2025, following the disclosure. The firm is preparing a class action lawsuit to recover investor losses.

JPM - Set a fresh record, stock price increased 1.90%
NJDCY - The company disclosed accounting issues in its China unit, leading to a 22.7% stock price decline and triggering a securities class action investigation. This represents material negative information that harmed shareholder value.
#securities fraud #accounting issues #class action lawsuit #investor losses #China unit probe #stock decline
Read More
Osisko Development and Electric Elements File Early Warning Report for Niobay Metals Inc.
GlobeNewswire Inc. • Na
Osisko Development and Electric Elements File Early Warning Report for Niobay Metals Inc.

12/23/2025 06:57 PM • Osisko Development Corp. acquired 8,571,429 units of Niobay Metals Inc. for $1.2 million on December 18, 2025, increasing its ownership stake from 10.8% to 12.3% on a basic basis. The investment was made through its subsidiary Barkerville Gold Mines Ltd. as part of Niobay's private placement offering.

GSpC - Set a fresh record, stock price increased 2.73%
ODV - Company is actively expanding its investment portfolio by acquiring a significant stake in Niobay Metals, demonstrating confidence in growth opportunities and strategic diversification beyond its flagship Cariboo Gold Project.
#private placement #equity investment #Niobay Metals #ownership stake #warrant acquisition #gold development #Cariboo Gold Project
Read More
Pelthos Therapeutics Expands Board of Directors with the Appointment of Andrew Einhorn
GlobeNewswire Inc. • Na
Pelthos Therapeutics Expands Board of Directors with the Appointment of Andrew Einhorn

12/23/2025 05:57 PM • Pelthos Therapeutics Inc. (NYSE American: PTHS) announced the appointment of veteran finance executive Andrew J. Einhorn to its Board of Directors effective immediately. Einhorn brings over four decades of experience in investment banking, capital markets, and C-level finance roles at life science companies. He will serve on the Audit Committee and Compensation Committee. The appointment increases the Pelthos Board to eight directors.

LLY - On pace for tenth gain in eleven sessions, stock price increased 1.89%
PTHS - The appointment of an experienced finance executive with 40+ years in investment banking and capital markets, combined with 20 years of CFO experience at biotech companies, signals strengthened financial leadership and governance. This is expected to support the company's growth as a newly public, commercially-focused biopharmaceutical company with an FDA-approved product (ZELSUVMI).
#board appointment #finance executive #biopharmaceutical #ZELSUVMI #molluscum contagiosum #FDA approval #capital markets #life science
Read More